A. Turcot, J. Stintzi, K. N. Xu, and . Raymond, Fast biological iron chelators: kinetics of iron removal from human diferric transferrin by multidentate hydroxypyridonates, Journal of Biological Inorganic Chemistry, vol.5, issue.5, pp.634-641, 2000.
DOI : 10.1007/s007750000149

E. V. Gorden, J. Xu, K. N. Raymond, and P. Durbin, Rational Design of Sequestering Agents for Plutonium and Other Actinides, Chemical Reviews, vol.103, issue.11, pp.4207-4282, 2003.
DOI : 10.1021/cr990114x

K. N. Datta and . Raymond, Gd???Hydroxypyridinone (HOPO)-Based High-Relaxivity Magnetic Resonance Imaging (MRI) Contrast Agents, Accounts of Chemical Research, vol.42, issue.7, pp.938-947, 2009.
DOI : 10.1021/ar800250h

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713805

J. Clevette, D. M. Lyster, W. O. Nelson, T. Rihela, G. A. Webb et al., Solution chemistry of gallium and indium 3-hydroxy-4-pyridinone complexes in vitro and in vivo, Inorganic Chemistry, vol.29, issue.4, pp.667-672, 1990.
DOI : 10.1021/ic00329a021

A. C. Chaves, S. M. Mendonça, M. I. Marques, A. C. Prata, A. F. Santos et al., A gallium complex with a new tripodal tris-hydroxypyridinone for potential nuclear diagnostic imaging: solution and in vivo studies of 67Ga-labeled species, Journal of Inorganic Biochemistry, vol.105, issue.1, pp.31-38, 2011.
DOI : 10.1016/j.jinorgbio.2010.09.012

K. E. Zhou, M. W. Baidoo, and . Brechbiel, Mapping biological behaviors by application of longer-lived positron emitting radionuclides, Advanced Drug Delivery Reviews, vol.65, issue.8, pp.1098-1111, 2013.
DOI : 10.1016/j.addr.2012.10.012

S. Gambhir, Molecular imaging of cancer with positron emission tomography, Nature Reviews Cancer, vol.2, issue.9, pp.683-693, 2002.
DOI : 10.1038/nrc882

W. Price, J. Greenman, and G. J. Stasiuk, Sc, Dalton Trans., vol.295, issue.Supplement, pp.15702-15724, 2016.
DOI : 10.1007/s00775-015-1318-7

J. W. Vosjan, L. R. Perk, G. W. Visser, M. Budde, P. Jurek et al., Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine, Nature Protocols, vol.7, issue.4, pp.739-743, 2010.
DOI : 10.1038/nprot.2010.13

J. Evans, J. P. Holland, S. L. Rice, M. G. Doran, S. M. Cheal et al., Imaging Tumor Burden in the Brain with 89Zr-Transferrin, Journal of Nuclear Medicine, vol.54, issue.1, pp.90-95, 2013.
DOI : 10.2967/jnumed.112.109777

S. Abou, T. Ku, P. M. Smith, and -. , In vivo biodistribution and accumulation of 89Zr in mice, Nuclear Medicine and Biology, vol.38, issue.5, pp.675-681, 2011.
DOI : 10.1016/j.nucmedbio.2010.12.011

Y. Guérard, R. Lee, L. P. Tripier, J. R. Szajek, M. W. Deschamps et al., ) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging, Chem. Commun., vol.23, issue.10, pp.1002-1004, 2013.
DOI : 10.1039/C2CC37549D

Y. Guérard, M. W. Lee, and . Brechbiel, Rational Design, Synthesis, and Evaluation of Tetrahydroxamic Acid Chelators for Stable Complexation of Zirconium(IV), Chemistry - A European Journal, vol.36, issue.19, pp.5584-5591, 2014.
DOI : 10.1002/chem.201304115

A. Patra, C. Bauman, C. A. Mari, O. Fischer, D. Blacque et al., An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes, Chem. Commun., vol.57, issue.78, pp.11523-11525, 2014.
DOI : 10.1039/C4CC05558F

D. Zhai, C. Summer, G. M. Rangger, P. Franssen, H. Laverman et al., Zr Labeling???Radiolabeling and Targeting Properties of RGD Conjugates, Molecular Pharmaceutics, vol.12, issue.6, pp.2142-2150, 2015.
DOI : 10.1021/acs.molpharmaceut.5b00128

URL : http://doi.org/10.1021/acs.molpharmaceut.5b00128

A. Deri, S. Ponnala, B. M. Zeglis, G. Pohl, J. J. Dannenberg et al., Zr Radiopharmaceuticals: Radiolabeling and Evaluation of 3,4,3-(LI-1,2-HOPO), Journal of Medicinal Chemistry, vol.57, issue.11, pp.4849-4860, 2014.
DOI : 10.1021/jm500389b

E. Rudd, P. Roselt, C. Cullinane, R. J. Hicks, and P. S. Donnelly, A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies, Chem. Commun., vol.9, issue.80, pp.11889-11892, 2016.
DOI : 10.1039/C6CC05961A

N. Pandya, S. Pailloux, D. Tatum, D. Magda, and T. J. Wadas, Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89, Chem. Commun., vol.5, issue.12, pp.2301-2303, 2015.
DOI : 10.1039/C4DT02978J

G. J. Captain, P. B. Deblonde, D. D. Rupert, M. An, E. Illy et al., Engineered Recognition of Tetravalent Zirconium and Thorium by Chelator???Protein Systems: Toward Flexible Radiotherapy and Imaging Platforms, Inorganic Chemistry, vol.55, issue.22, pp.11930-11936, 2016.
DOI : 10.1021/acs.inorgchem.6b02041

W. Price, B. M. Zeglis, J. S. Lewis, M. J. Adam, and C. Orvig, Lu, Dalton Trans., vol.121, issue.1, pp.119-131, 2013.
DOI : 10.1039/C3DT51940F

T. Ma, L. K. Meszaros, B. M. Paterson, D. J. Berry, M. S. Cooper et al., : comparison with desferrioxamine-B, Dalton Trans., vol.23, issue.11, pp.4884-4900, 2015.
DOI : 10.1039/C4DT02978J

A. Deri, S. Ponnala, P. Kozlowski, B. P. Burton-pye, H. T. Cicek et al., Zr ImmunoPET, Bioconjugate Chemistry, vol.26, issue.12, pp.2579-2591, 2015.
DOI : 10.1021/acs.bioconjchem.5b00572

Y. M. Piyamongkol, X. L. Ma, Z. D. Kong, M. D. Liu, D. Aytemir et al., Amido-3-hydroxypyridin-4-ones as Iron(III) Ligands, Chemistry - A European Journal, vol.68, issue.21, pp.6374-6381, 2010.
DOI : 10.1002/chem.200902455

D. Liu, S. Piyamongkol, D. Y. Liu, H. H. Khodr, S. L. Lu et al., Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values, Bioorganic & Medicinal Chemistry, vol.9, issue.3, pp.563-573, 2001.
DOI : 10.1016/S0968-0896(00)00273-X

S. N. Lambert, H. K. Chittamuru, A. S. Jacobs, and . Gopalan, New methodology for the preparation of 3-hydroxy-2-pyridinone (3,2-HOPO) chelators???reaction of amines with a novel electrophilic 3,2-HOPO precursor, Tetrahedron Letters, vol.43, issue.41, pp.7379-7383, 2002.
DOI : 10.1016/S0040-4039(02)01730-6

S. Dobbin, R. C. Hider, A. D. Hall, P. D. Taylor, P. Sarpong et al., Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential, Journal of Medicinal Chemistry, vol.36, issue.17, pp.2448-2458, 1993.
DOI : 10.1021/jm00069a002

S. J. Xu, D. W. Franklin, K. N. Whisenhunt, and . Raymond, Gadolinium complex of tris[(3-hydroxy-1-methyl- 2-oxo-1,2-didehydropyridine-4-carboxamido)ethyl]-amine: A New Class of gadolinium magnetic resonance relaxation agents, Journal of the American Chemical Society, vol.117, issue.27, pp.7245-7246, 1995.
DOI : 10.1021/ja00132a025

B. Harder, F. Kuhn, and . Diederich, Efficient Stacking on Protein Amide Fragments, ChemMedChem, vol.58, issue.3, pp.397-404, 2013.
DOI : 10.1002/cmdc.201200512

B. Tomasi, R. Mennucci, and . Cammi, Quantum Mechanical Continuum Solvation Models, Chemical Reviews, vol.105, issue.8, pp.2999-3093, 2005.
DOI : 10.1021/cr9904009